Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
163.8 USD | +1.36% | +2.08% | +5.69% |
May. 15 | Transcript : AbbVie Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM | |
May. 15 | Medincell: share price falls after disappointing clinical study | CF |
Evolution of the average Target Price on AbbVie Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AbbVie Inc.
Daiwa Securities | |
BMO Capital | |
Mizuho Securities | |
Barclays | |
Deutsche Bank Securities | |
UBS | |
Truist Securities | |
Piper Sandler | |
Morningstar | |
Wells Fargo Securities | |
Goldman Sachs | |
Raymond James | |
William Blair & Co. | |
BofA Securities | |
HSBC | |
Morgan Stanley | |
Guggenheim | |
Argus | |
Wolfe Research | |
Atlantic Equities | |
SVB Securities LLC | |
Credit Suisse | |
Societe Generale | |
Berenberg Bank | |
JPMorgan Chase | |
Cowen | |
Redburn | |
SVB Leerink | |
RBC Capital Markets |
EPS Revisions
- Stock Market
- Equities
- ABBV Stock
- Consensus AbbVie Inc.